BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29845313)

  • 1. Medial prefrontal cortex TRPV1 and CB1 receptors modulate cardiac baroreflex activity by regulating the NMDA receptor/nitric oxide pathway.
    Lagatta DC; Kuntze LB; Ferreira-Junior NC; Resstel LBM
    Pflugers Arch; 2018 Oct; 470(10):1521-1542. PubMed ID: 29845313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medial prefrontal cortex N-methyl-D-aspartate receptor/nitric oxide/cyclic guanosine monophosphate pathway modulates both tachycardic and bradycardic baroreflex responses.
    Ferreira-Junior NC; Fedoce AG; Alves FH; Resstel LB
    J Neurosci Res; 2013 Oct; 91(10):1338-48. PubMed ID: 23913674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of the contextual conditioned emotional response by CB1 and TRPV1 receptors in the ventromedial prefrontal cortex: Possible involvement of NMDA/nitric oxide-related mechanisms.
    Uliana DL; Antero LS; Borges-Assis AB; Rosa J; Vila-Verde C; Lisboa SF; Resstel LB
    J Psychopharmacol; 2020 Sep; 34(9):1043-1055. PubMed ID: 32638638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
    Uliana DL; Hott SC; Lisboa SF; Resstel LB
    Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medial prefrontal cortex TRPV1 channels modulate the baroreflex cardiac activity in rats.
    Lagatta DC; Ferreira-Junior NC; Resstel LB
    Br J Pharmacol; 2015 Nov; 172(22):5377-89. PubMed ID: 26360139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial prefrontal cortex NMDA receptors and nitric oxide modulate the parasympathetic component of the baroreflex.
    Resstel LB; Corrêa FM
    Eur J Neurosci; 2006 Jan; 23(2):481-8. PubMed ID: 16420454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CB
    Sartim AG; Moreira FA; Joca SRL
    Neuroscience; 2017 Jan; 340():126-134. PubMed ID: 27771531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB
    Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
    Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of l-glutamate into medial prefrontal cortex induces cardiovascular responses through NMDA receptor - nitric oxide in rat.
    Resstel LB; Corrêa FM
    Neuropharmacology; 2006 Jul; 51(1):160-7. PubMed ID: 16678863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bed nucleus of the stria terminalis modulates baroreflex cardiac activity: an interaction between alpha-1 receptors and NMDA/nitric oxide pathway.
    Lagatta DC; Kuntze LB; Uliana DL; Borges-Assis AB; Resstel LBM
    Pflugers Arch; 2021 Feb; 473(2):253-271. PubMed ID: 33140200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventromedial prefrontal cortex CRF1 receptors modulate the tachycardic activity of baroreflex.
    Brufatto JPT; Lagatta DC; Uliana DL; Firmino EMS; Borges-Assis AB; Resstel LBM
    Pflugers Arch; 2021 Apr; 473(4):697-709. PubMed ID: 33839941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bed nucleus of the stria terminalis N-methyl-D-aspartate receptors and nitric oxide modulate the baroreflex cardiac component in unanesthetized rats.
    Alves FH; Crestani CC; Resstel LB; Correa FM
    J Neurosci Res; 2009 May; 87(7):1703-11. PubMed ID: 19156861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test.
    Pereira VS; Romano A; Wegener G; Joca SR
    Psychopharmacology (Berl); 2015 Jul; 232(13):2263-73. PubMed ID: 25589143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB(1) receptors.
    Ferreira-Junior NC; Fedoce AG; Alves FH; Corrêa FM; Resstel LB
    Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(7):R876-85. PubMed ID: 22204950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex.
    Resstel LB; Corrêa FM; Guimarães FS
    Cereb Cortex; 2008 Sep; 18(9):2027-35. PubMed ID: 18158326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contextual fear expression engages a complex set of interactions between ventromedial prefrontal cortex cholinergic, glutamatergic, nitrergic and cannabinergic signaling.
    Uliana DL; Diniz CRAF; da Silva LA; Borges-Assis AB; Lisboa SF; Resstel LBM
    Neuropharmacology; 2023 Jul; 232():109538. PubMed ID: 37024011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ventral hippocampus NMDA receptor/nitric oxide/guanylate cyclase pathway modulates cardiovascular responses in rats.
    Santini CO; Fassini A; Scopinho AA; Busnardo C; Corrêa FM; Resstel LB
    Auton Neurosci; 2013 Oct; 177(2):244-52. PubMed ID: 23735844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dorsal hippocampus glutamatergic and nitrergic neurotransmission in autonomic responses evoked by acute restraint stress in rats.
    Moraes-Neto TB; Scopinho AA; Biojone C; Corrêa FM; Resstel LB
    Neuroscience; 2014 Jan; 258():364-73. PubMed ID: 24269610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor type 1 in the bed nucleus of the stria terminalis modulates cardiovascular responses to stress via local N-methyl-D-aspartate receptor/neuronal nitric oxide synthase/soluble guanylate cyclase/protein kinase G signaling.
    Gomes-de-Souza L; Costa-Ferreira W; Oliveira LA; Benini R; Crestani CC
    J Psychopharmacol; 2020 Apr; 34(4):429-440. PubMed ID: 31913077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.